Detalhe da pesquisa
1.
"So at least now I know how to deal with things myself, what I can do if it gets really bad again"-experiences with a long-term cross-sectoral advocacy care and case management for severe multiple sclerosis: a qualitative study.
BMC Health Serv Res
; 24(1): 453, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38600493
2.
Cerebrospinal Fluid Analysis Post-COVID-19 Is Not Suggestive of Persistent Central Nervous System Infection.
Ann Neurol
; 91(1): 150-157, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34724243
3.
Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome.
Brain Behav Immun
; 109: 139-143, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36657623
4.
Cultural adaptation of the Integrated Palliative care Outcome Scale for neurological symptoms.
Palliat Support Care
; : 1-10, 2023 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37039454
5.
Cultural adaptation of the Integrated Palliative care Outcome Scale for neurological symptoms - ERRATUM.
Palliat Support Care
; : 1, 2023 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37211899
6.
Persons with multiple sclerosis older than 55 years: an analysis from the German MS registry.
J Neurol
; 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38517521
7.
Cognitive decline in post-COVID-19 syndrome does not correspond with persisting neuronal or astrocytic damage.
Sci Rep
; 14(1): 5326, 2024 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38438479
8.
Cerebrospinal fluid findings in patients with neurological manifestations in post-COVID-19 syndrome.
J Neurol
; 271(1): 59-70, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37999770
9.
Development of a Long-Term Cross-Sectoral Case and Care Management Manual for Patients With Severe Multiple Sclerosis and Their Caregivers.
Prof Case Manag
; 28(4): 183-193, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36518082
10.
Multidomain cognitive impairment in non-hospitalized patients with the post-COVID-19 syndrome: results from a prospective monocentric cohort.
J Neurol
; 270(3): 1215-1223, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36422669
11.
Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Diseases: COPANMO(G)-Study.
Neurol Neuroimmunol Neuroinflamm
; 10(2)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36693760
12.
Communication, Coordination, and Security for People with Multiple Sclerosis (COCOS-MS): a randomised phase II clinical trial protocol.
BMJ Open
; 12(1): e049300, 2022 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35078833
13.
Successful treatment of thromboses of major arteries after ChAdOx1 nCov-19 vaccination.
Neurol Res Pract
; 3(1): 52, 2021 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34602097
14.
Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.
Neurol Neuroimmunol Neuroinflamm
; 8(5)2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34261812